Colorectal Cancer (CRC) Cell and Gene Therapy Market in 8MM – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)

Colorectal Cancer Cell and Gene Therapy Market – Report Overview

Pacific Business Consulting’s “Colorectal Cancer (CRC) Cell and Gene Therapy Market in 8MM – Market Outlook, Unmet Needs, Market Assessment and Forecast (2023-2030)” report offers a comprehensive understanding of Colorectal Cancer Cell and Gene Therapy, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Eight Major Markets (8MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and China.

The market size for Colorectal Cancer (CRC) 15, encompassing both Chimeric Antigen Receptor T-cell (CGT) therapies and established/conventional treatments, reached an estimated value of US$19.7 billion in 2022. CRC boasts one of the most extensive gene therapy/oncolytic virus clinical pipelines in the realm of oncology, along with a relatively active clinical cell therapy pipeline compared to other solid tumors. Despite this, there are currently no marketed or Phase III CGT agents in CRC, primarily due to the challenges associated with advancing these drug types into the CRC market. The predominant obstacle lies in their insufficient efficacy; however, there is considerable clinical potential for a CGT agent demonstrating long-term disease control in metastatic CRC.

Anticipated changes in the Colorectal Cancer market in the upcoming years are attributed to increasing disease awareness and incremental healthcare spending globally. These factors are expected to expand the market size, providing drug manufacturers with greater opportunities to penetrate the market. Colorectal Cancer companies and academic institutions are actively addressing challenges and exploring opportunities that could influence Colorectal Cancer Research and Development (R&D). Therapies currently in development are centered around novel approaches aimed at treating and improving the disease condition.

Key players in this segment include F-Hoffmann-La Roche Ltd, Immunovative Therapies Ltd, Turnstone Biologics Inc., Alaunos Therapeutics Inc, Yangshengtang Biotech Co Ltd, Iovance Biotherapeutics, Transgene SA, Replimune Ltd, and Bristol-Myers Squibb Co.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Colorectal Cancer market. It also delves into the analysis of present and prospective market competition within the global Colorectal Cancer market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Colorectal Cancer market across the 8MM (Eight Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 8MM Colorectal Cancer market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Please note that detailed pipeline analysis can be provided along with the standard scope to assist you in developing and designing your in-licensing and out-licensing strategies. This includes a review of pipeline products and technologies, along with identifying companies with the most robust pipeline.

1. Executive Summary: Colorectal Cancer (CRC) Cell and Gene Therapy
   • Global Market Outlook: Colorectal Cancer (CRC) Cell and Gene Therapy
2. Competitive Intelligence Analysis: Colorectal Cancer (CRC) Cell and Gene Therapy
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Colorectal Cancer (CRC) Cell and Gene Therapy
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Disease Overview: Colorectal Cancer (CRC) Cell and Gene Therapy
   • Disease Etiology
   • Pathophysiology
   • Risk Factors
   • Treatment Algorithm
7. Colorectal Cancer (CRC) Cell and Gene Therapy: Key Marketed Products Profile – Major Approved Products
   • Product Profile
   • Regulatory Milestones
   • Safety and Efficacy
   • Clinical Development
8. Colorectal Cancer (CRC) Cell and Gene Therapy: Promising Pipeline Candidates – Major Products in Late Stage of Development
   • Product Description
   • Safety and Efficacy
   • Research and Development
9. Regulatory Landscape
10. Colorectal Cancer (CRC) Cell and Gene Therapy: Eight Major Market (8MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
11. S. Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
12. K. Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
13. Germany Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
14. France Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
15. Italy Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
16. Spain Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
17. Japan Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
18. China Colorectal Cancer (CRC) Cell and Gene Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
19. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

20. Assumptions and Acronyms Used
21. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
22. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, and China
23. Copyrights and Disclaimer